MRCEM Primary worth doing before ST1 interview
Authoritative sources
- RCEM — MRCEM Primary exam
- Oriel — NHS recruitment portal
- RCEM — Training pathways
- GMC — General Medical Council
Facts last verified .
TL;DR
Pre-passing the MRCEM Primary before ACCS-EM ST1 does not earn you a defined score on the 2026 application. ACCS-EM ST1 is shortlisted and ranked on MSRA (40%) plus a virtual interview (60%). There is no self-assessment matrix at this stage (that comes at ST3). What MRCEM Primary does buy you is a credible “commitment to specialty” line in the portfolio station, a useful conversation anchor at interview, and roughly 6–9 months of head-start on the MRCEM SBA you will have to pass anyway. It also costs around £429–£525 in fees and 3–6 months of focused revision time that could otherwise go into a re-audited QI project, a published case report, or MSRA practice. Those alternatives arguably move your ranking more. The honest answer: worth it if you are confident EM is your path and you want the exam programme started early; not worth it if it would crowd out the things that genuinely score (MSRA performance, structured portfolio evidence, interview rehearsal).
How the ACCS-EM ST1 application is actually scored in 2026
For the August 2026 intake, recruitment to ACCS-EM is run-through at ST1 and the selection method is unchanged from recent cycles: a 40% MSRA weighting plus a 60% virtual interview weighting. If applicant volume exceeds interview capacity (around 882 in the most recent cycle), shortlisting is done on total MSRA score alone. The interview runs on Qpercom as two 10-minute stations (one portfolio, one clinical/ethical) scored by a two-member panel.
Critically, there is no Oriel self-assessment scoring matrix at ST1. That structured points-per-line-item form (postgraduate degrees, publications, presentations, etc.) is an ST3 EM and ST3 DRE-EM feature, not an ST1 one. So when candidates ask “how many points does MRCEM Primary score?”, the technically accurate answer at ST1 is: zero defined points, because there is no scoring grid for it to sit in.
Does MRCEM Primary score anywhere on the ST1 application?
Not as a discrete line item. The 2026 ACCS-EM CT1 person specification lists “engagement with relevant RCEM examinations” under desirable criteria, alongside QI, teaching and research. A passed MRCEM Primary is the cleanest possible evidence of that engagement, but it is assessed qualitatively at interview rather than scored on a points grid.
In practical terms, this means a pass can:
- Earn you a stronger response in the portfolio station when the panel probes commitment to EM.
- Sit on your CV as a concrete deliverable rather than a stated intention.
- Free up training time post-ST1, because you only need MRCEM SBA and OSCE done by end of ST3 (ST4 for run-through).
What it will not do is move you up a defined number of ranks the way a re-audited QI project with measurable outcomes might shift your portfolio station score.
How much does MRCEM Primary actually help in the interview?
The portfolio station is 10 minutes and asks about commitment to specialty, teaching, QI, leadership and reflective practice. Panellists are looking for evidence-backed, structured answers. Saying “I have already passed MRCEM Primary” is a one-sentence proof of EM commitment. It is useful, but not station-winning on its own.
Candidates who score well in the portfolio station typically combine several signals: a completed re-audit cycle with measurable outcome, a formal teaching role with documented feedback, a relevant course or conference, and ideally one piece of EM-flavoured scholarly output (poster, abstract, case report). MRCEM Primary slots in as one signal among several. It is rarely the single thing that gets a candidate ranked.
What does it cost in time and money?
For 2026 sittings, RCEM fees are £429 for UK members and £525 for UK non-members (international rates are higher). Add £200–£600 if you use a question bank or paid course. The exam is 180 single best answer questions over three hours, sat twice a year. Most successful candidates report 3–6 months of structured revision, typically 1–2 hours per evening plus weekend blocks, with pass rates hovering around 57% (RCEM data, 2024 sitting).
The realistic opportunity cost for an F2 or IMT-1 is one academic block of “discretionary CV time”: the same window where you could complete a re-audit, run a teaching series with formal feedback, or grind MSRA practice questions. That trade-off is the actual decision, not the exam itself.
MRCEM Primary vs other portfolio plays: a comparison
| Activity | Effort (revision/work hours) | Direct ST1 scoring impact | Opportunity cost | Downstream benefit |
|---|---|---|---|---|
| MRCEM Primary pass | ~150–300 hours over 3–6 months | Indirect: qualitative interview signal | High (crowds out other CV work) | One MRCEM exam done; faster path to MRCEM SBA |
| MSRA practice (UWorld/Passmedicine + mocks) | ~80–150 hours over 2–3 months | Direct: affects 40% of total score | Low/medium | Also useful for IMT/GP applications |
| Completed re-audit with outcome | ~40–80 hours over 6 months | Strong qualitative portfolio signal | Low (runs in clinical time) | Reusable evidence across multiple applications |
| Teaching programme with formal feedback | ~20–40 hours | Strong qualitative portfolio signal | Low | Reusable; supports later ARCP |
| Published case report or abstract | ~30–60 hours | Moderate portfolio signal | Medium | Counts at ST3 self-assessment |
| MRCS Part A / MRCP Part 1 | ~150–300 hours | Negligible for EM ST1 specifically | Very high | Only useful if hedging into surgery/medicine |
The pattern: MSRA performance and a tight, evidenced portfolio do the heavy lifting for the 100% of the ranking that is actually scored. MRCEM Primary adds texture, not points.
Will MRCEM Primary speed up my training?
Yes, modestly. The MRCEM is a three-part exam: Primary (basic sciences SBA), Intermediate SBA (clinical SBA) and OSCE. All three must be completed before transitioning to higher specialty training. For run-through ACCS-EM trainees that means by the end of ST4. Pre-passing the Primary as an F2 or IMT-1 means one fewer exam to organise around ACCS-1 and ACCS-2 placements, which are already heavy on anaesthetics, ICM and acute medicine rotations with limited study leave protection.
It is genuinely useful to have the basic sciences (anatomy, physiology, pharmacology, microbiology, evidence-based medicine) recently revised when you start ACCS, because the Intermediate SBA assumes those foundations.
Is the time better spent on QI, audit or teaching?
For most candidates with limited CV evidence, yes, at least until your portfolio has one completed re-audit cycle, one formal teaching role and at least one piece of EM-relevant scholarly output. Those items appear directly in the structured portion of the portfolio station and continue to score at ST3 self-assessment, where they are explicitly graded on a points matrix.
If your portfolio already has those covered and you have headroom, MRCEM Primary becomes a much more reasonable use of the next revision block. The order matters: build the portfolio that actively scores, then add the exam that signals commitment.
What does it signal if you sit MRCEM Primary before ST1 and fail?
Honestly: less than candidates fear, but more than zero. A single fail is not asked about on the application form and is not visible to the panel unless you mention it. RCEM does not publish individual results. So the direct reputational damage is essentially nil.
The real cost of a fail is internal: the time and emotional drain of a re-sit window that now overlaps with ST1 application season, the £400–£600 second fee, and the dent in confidence going into the MSRA. The honest decision-support framing: if you sit it pre-ST1, sit it when you are genuinely revision-ready (mock exams in the 70%+ range), not just because the calendar pushes you to. A premature attempt is the version of this that actually hurts.
Is MRCEM Primary better than MRCS Part A or MRCP Part 1 as an ST1 signal?
For EM specifically, yes, clearly. MRCEM Primary maps onto the specialty you are applying to. MRCS Part A and MRCP Part 1 demonstrate exam capability but are not specialty-aligned, and panellists may reasonably ask why you sat them. The exception is the candidate genuinely hedging between specialties, where MRCP Part 1 keeps IMT options alive. That is a different decision-tree entirely. See our piece on the overlap between MRCEM, MSRA and MRCS exams for the breakdown of what shared content actually exists.
When should you sit MRCEM Primary if you do decide to?
For most candidates, the cleanest windows are:
- FY2 autumn or spring sitting, if you have decided early on EM and want the exam done before ACCS-1 rotations begin.
- IMT-1 spring sitting, if you started in IMT but are switching to ACCS-EM; this builds in re-sit headroom before the autumn application opens.
- Avoid sitting in the immediate run-up to the MSRA window or the virtual interview window, because splitting revision focus tends to weaken both.
If you are already in ACCS-1 and applying for ST3 EM or DRE-EM, the calculation flips entirely. See our ST3 portfolio preparation guide, because at ST3 the self-assessment scoring grid is real and points-based, and exam progress is explicitly assessed.
The honest decision-support take
MRCEM Primary before ST1 is a reasonable, defensible choice that produces real but bounded benefit. It is not a tick-box scoring lever. It is a CV signal, a training accelerator, and a credible answer to “why EM?”. The candidates who regret sitting it tend to be the ones who underestimated the revision time or sacrificed MSRA preparation for it. The candidates who get value from it tend to be the ones who already had the portfolio basics in place and used it as the final commitment signal.
If you are weighing this and your portfolio still has gaps, fix the gaps first. If your portfolio is solid and you have a revision window, the Primary is a sensible next step.
Frequently asked questions
The FAQ section is rendered from structured data below the post.
Ready to build your plan? EMF Premium gives you all 40,000 questions and 20 mocks for £59 — one payment, six months' access.